Skip to Main Content
Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination
Issue Cover
Current Issue
Volume 45,
Issue 5
May 2022
View This Issue

About the Journal

"[T]he simple word Care may suffice to express [the journal’s] philosophical mission", "to promote better patient care by serving the expanded needs of all health professionals committed to the care of patients with diabetes." Read more.

Editor-in-Chief

Matthew C. Riddle, MD
Oregon Health & Science University
View Full Editorial Board

Impact Factor

19.112

ADA Standards of Medical Care in Diabetes — 2022: Now Available Online

Untitled Document

Current Issue Highlights

Diabetes Care Volume 45, Issue 5

PATHOPHYSIOLOGY/COMPLICATIONS | DECEMBER 08 2021

Pregnancy Outcomes in Young Women With Youth-Onset Type 2 Diabetes Followed in the TODAY Study

 
PATHOPHYSIOLOGY/COMPLICATIONS | SEPTEMBER 14 2021

Development and Progression of Diabetic Retinopathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study

PATHOPHYSIOLOGY/COMPLICATIONS | SEPTEMBER 14 2021

Effects of Metabolic Factors, Race-Ethnicity, and Sex on the Development of Nephropathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study


PATHOPHYSIOLOGY/COMPLICATIONS | MARCH 09 2022

Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study

Online Ahead of Print
Effect of Deintensifying Diabetes Medications on Negative Events in Older Veteran Nursing Home Residents
Association of HLA-DQ Heterodimer Residues −18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial–Type 1
Erratum. Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes. Diabetes Care 2020;43:460–467
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience
Time With Diabetes Distress and Glycemia-Specific Distress: New Patient-Reported Outcome Measures for the Psychosocial Burden of Diabetes Using Ecological Momentary Assessment in an Observational Study
Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial
Browse All
Introduction: Standards of Medical Care in Diabetes—2022
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021

Follow ADA Publications on Twitter 

Join us on Twitter @ADA_Pubs to connect with the diabetes research community and share ideas with fellow professionals. Find the newest published articles, latest podcasts, new professional books, and up-to-date diabetes news. You can also follow us on Facebook @adaPublications.

Professional Books Site Now Live!

ADA’s professional books now appear alongside journal content and multimedia for a more complete research discovery experience. Browse or search today! Professional Books

SGLT2 Inhibitors and Diabetic Kidney Disease

In this special episode of the Diabetes Core Update podcast, Drs. Neil Skolnik & John Russell discuss the beneficial effects of SGLT2 inhibitors on kidney function. Recent trials have shown that SGLT2 inhibitors can help slow the progression of diabetic kidney disease & chronic kidney disease.

  • Online ISSN 1935-5548
  • Print ISSN 0149-5992

Journals

Books

Clinical Compendia

News

Other

About

Resources

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept